Lotronex 0.5 mg Oral Tablet
RxNorm 540181
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 540181 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Lotronex 0.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Alosetron 0.5 mg Oral Tablet [Lotronex]
(Atom ID: 2254150)
SYPrescribable
Synonym (SY):
Lotronex 0.5 mg (alosetron hydrochloride 0.562 mg) Oral Tablet
(Atom ID: 3066780)
PSNPrescribable
Prescribable Name (PSN):
Lotronex 0.5 mg Oral Tablet
(Atom ID: 6370136)
SYPrescribable
Synonym (SY):
Lotronex 0.5 mg Oral Tablet
(Atom ID: 2254151)
Patient Education
Alosetron
Alosetron is used to treat diarrhea, pain, cramps, and the feeling of an urgent need to have bowel movements caused by irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea) in women who have diarrhea as their main symptom and have not been helped by other treatments. Alosetron is in a class of medications called 5-HT3 receptor antagonists. Alosetron works by slowing the movement of stool (bowel movements) through the intestines.
[Learn More]
* Please review the disclaimer below.